you have symptoms of coronavirus (COVID-19) – a high temperature, a new continuous cough, or a loss of, or change in, your normal sense of smell or taste (anosmia) – the advice is to stay at home for 10 days. Information on self-isolation rules if a member of your household tests positive for Covid-19 or if you are classed as a contact, can be found here.

If you think you have symptoms, please do not attend your hospital appointment until you are advised it is safe to do so. Please contact us to rearrange your appointment, or to re-organise treatment and tests.

The latest information on the Covid-19 vaccination programme in Nottingham and Nottinghamshire can be found here

Interstitial Lung Disease

NUH is host to the regional centre for interstitial lung disease (ILD) and the national lymphangioleiomyomatosis (LAM) centre, providing care for patients with ILDs from across the East Midlands and nationally for patients with LAM.

Interstitial lung diseases (ILDs) affect mainly the lung tissue (parenchyma) and include idiopathic pulmonary fibrosis, asbestosis, sarcoidosis, connective tissue disease related lung diseases and hypersensitivity pneumonitis as well as rarer interstitial lung diseases including LAM.

Idiopathic pulmonary fibrosis (IPF) is the most common and most serious of the ILDs, affecting approximately 5,000 people in the UK. It leads to progressive shortness of breath which is not usually noticeable at rest but severely limits any exertion such as walking very short distances. It also leads to a debilitating dry cough.

World-leading research

Through the NIHR Nottingham Biomedical Research Centre, we are increasing our knowledge and understanding of respiratory diseases. Our research is designed to translate research results into new drugs, therapies and treatments to improve the care we can offer to patients.

Contact us

Tel: 0115 823 1710

The nurses are available Monday- Friday 9am - 5pm